Zobrazeno 1 - 10
of 127
pro vyhledávání: '"S.A. Bhide"'
Autor:
A. Hunt, Thomas Bird, I. White, S.A. Bhide, Susan Lalondrelle, D. McQuaid, Heba Soliman, David P. Dearnaley, S. Settatree
Publikováno v:
The British Journal of Radiology
Objectives: Quantify target volume delineation uncertainty for CT/MRI simulation and MRI-guided adaptive radiotherapy in rectal cancer. Define optimal imaging sequences for target delineation. Methods: Six experienced radiation oncologists delineated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::befdafc3550d074e2897ecb42a9a754b
https://doi.org/10.1259/bjr.20210350
https://doi.org/10.1259/bjr.20210350
Autor:
Matthew Griffin, A. Michaelidou, Niveditha Singh, Paul Sanghera, Petra Jankowska, Laura Pettit, Emma De Winton, L. O'Toole, Konstantinos Geropantas, S.A. Bhide, Rafael Moleron, Mano Joseph, S. Schipani, Anthony Kong Conceptualisation, Ifigenia Vasiliadou, B. Foran, Teresa Guerrero Urbano, Andrew Hartley, David Noble, Kannon Nathan, Rebecca Goranova, Dorothy M. Gujral, Jonathan Chambers, Mehmet Sen, Ketan A. Shah, Anoop Haridass
Publikováno v:
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology, Vol 30, Iss, Pp 50-59 (2021)
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY
Clinical and Translational Radiation Oncology, Vol 30, Iss, Pp 50-59 (2021)
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY
Background The onset of the COVID-19 pandemic necessitated rapid changes to the practice of head and neck oncology in UK. There was a delay between the onset of the pandemic and the release of guidelines from cancer societies and networks, leading to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25c37f7e9a330762b048b6dba192b386
https://pubmed.ncbi.nlm.nih.gov/34226880
https://pubmed.ncbi.nlm.nih.gov/34226880
Autor:
Mary Lei, Charles Fong, Christopher M. Nutting, Ifigenia Vasiliadou, Kate Newbold, Andrew Hartley, S.A. Bhide, Imran Petkar, Gemma Hegarty, Anthony Kong, Teresa Guerrero Urbano, Paul Sanghera, Andriana Michaelidou, Isla Leslie, J. Good, Kannon Nathan, Miguel Reis Ferreira, Van Ren Sim, Kevin J. Harrington, KH Wong, Omar Breik, Holly Baker
Publikováno v:
Cancers, Vol 13, Iss 1413, p 1413 (2021)
Cancers
Volume 13
Issue 6
Cancers
Volume 13
Issue 6
Simple Summary Nivolumab is an anti-PD-1 monoclonal antibody that has been approved in the management of recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) with evidence of progression within 6 months of platinum-based chemotherapy. M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0129408e7bcead249d2e9ad317830249
https://www.mdpi.com/2072-6694/13/6/1413
https://www.mdpi.com/2072-6694/13/6/1413
Autor:
B. Foran, M. Sydenham, Justin W. G. Roe, Keith Rooney, Matthew Beasley, M. Emson, S.A. Bhide, Robert Frogley, Imran Petkar, Laura Finneran, Christopher M. Nutting, Emma Hall, Laura Pettit, Justine Tyler
Publikováno v:
Oral Oncology. 118:10-11
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d205ba84f274dd51af159f461c2b1bad
https://doi.org/10.1016/s1368-8375(21)00346-8
https://doi.org/10.1016/s1368-8375(21)00346-8
Autor:
Lucinda Gunn, S.A. Bhide, Kate Newbold, Christopher M. Nutting, KH Wong, James Gilbert, Heba Soliman, Kevin J. Harrington, Pablo Nenclares
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 157
Background An intact sense of taste provides pleasure, supports sustenance and alerts the body to toxins. Head and neck cancer (HNC) patients who receive radiotherapy (RT) are high-risk for developing radiation-induced taste dysfunction. Advances in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::191f84cec62bc5ffd7752f8768574b88
https://pubmed.ncbi.nlm.nih.gov/33545253
https://pubmed.ncbi.nlm.nih.gov/33545253
Autor:
Anthony Kong, Alan Melcher, Pablo Nenclares, Heba Soliman, KH Wong, R. Metcalf, Robin Prestwich, Christopher M. Nutting, Martin Forster, J. Good, Katie L. Newbold, Joseph J. Sacco, Kevin J. Harrington, Lucinda Gunn, S.A. Bhide
Publikováno v:
Clinical Oncology (Royal College of Radiologists (Great Britain)
Clinical Oncology
Clinical Oncology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6dc26a0a89149332f2bd5d51ad35395a
https://pubmed.ncbi.nlm.nih.gov/32513517
https://pubmed.ncbi.nlm.nih.gov/32513517
Autor:
Mansour T. A. Sharabiani, Paul Carter, S.A. Bhide, Kevin J. Harrington, R. Shaikh, Isaac Garcia-Murillas, D.M. Allin, Katie L. Newbold, Khin Thway, D. Kim, D. Gonzales-de-Castro, Ben O'Leary, Mike Hubank
Publikováno v:
European Journal of Cancer. 103:165-175
Background Conventional biomarkers in thyroid cancer are not disease specific and fluctuate in advanced disease, making interpretation difficult. Circulating tumour DNA (ctDNA) has been shown to be a useful biomarker in other solid tumours. This is a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a249d970699bdee9e0429b22953ef523
https://doi.org/10.1016/j.ejca.2018.08.013
https://doi.org/10.1016/j.ejca.2018.08.013
Autor:
H. Barnes, Robert Huddart, S.A. Bhide, T. Herbert, Alison Tree, Helen McNair, Shaista Hafeez, G. Smith, I. Hanson, Simeon Nill, R. Lawes, Sarah Helyer
Publikováno v:
Radiography. 26:S1-S2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::faac062401b94247c9e519635c464f97
https://doi.org/10.1016/j.radi.2019.11.007
https://doi.org/10.1016/j.radi.2019.11.007
Autor:
Catherine Lemon, Dorothy M. Gujral, Paul Sanghera, James P Morden, Emma Hall, M. Emson, Simon Gollins, Q van den Blink, Matthew Beasley, L. Fresco, Mererid Evans, L Luxon, S.A. Bhide, E. Wells, Katie L. Newbold, Costar Investigators, Christopher M. Nutting, E. De Winton, M. Sivaramalingam, Kevin J. Harrington, Audrey Cook, Stephanie Witts, M Joseph, N. N Srihari, M. Sydenham, R Mendes, Martin Robinson, J Simpson, Robin Prestwich, A Miah
Publikováno v:
European Journal of Cancer
Purpose About 40–60% of patients treated with post-operative radiotherapy for parotid cancer experience ipsilateral sensorineural hearing loss. Intensity-modulated radiotherapy (IMRT) can reduce radiation dose to the cochlea. COSTAR, a phase III tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2407c2110c5387ab984356defec124f
https://pubmed.ncbi.nlm.nih.gov/30286418
https://pubmed.ncbi.nlm.nih.gov/30286418
Autor:
Lorna Grove, Christopher M. Nutting, M.T. Guerrero-Urbano, Kevin J. Harrington, Aisha Miah, Mansour T. A. Sharabiani, Katie L. Newbold, Keith Rooney, S.A. Bhide
Background and purpose To determine the safety and tolerability of dose-escalation using modestly accelerated IMRT in high-risk locally advanced thyroid cancer requiring post-operative radiotherapy, and to report preliminary data on efficacy. Materia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9640c95700c6dd446fb5e3771ed42c15
http://hdl.handle.net/10044/1/85213
http://hdl.handle.net/10044/1/85213
